6.910USD-8.17%Mkt Cap: 201.85M USDP/E: —Last update: 2026-06-01
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimer…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap201.85M USD
Enterprise Value115.63M USD
Revenue (TTM)1.77M USD
Gross Profit-61.05M USD
Net Income (TTM)-130.30M USD
Revenue/Share0.0680 USD
Last Price6.910 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.81
PEG—
EV/EBITDA-1.30
EV/Revenue65.14
P/S124.81
P/B-1.45
EPS (TTM)-5.80
EPS (Forward)-2.68
52W Range
5.60013% of range15.57
52W High15.57 USD
52W Low5.600 USD
Profitability
Gross Margin0.00%
Oper. Margin-33973.08%
EBITDA Margin0.00%
Profit Margin-4658.63%
ROE103.22%
ROA-43.96%
Growth
Revenue Growth-92.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-73.94M USD
CapEx (TTM)5.45M USD
FCF Margin-2640.61%
FCF Yield-23.22%
Net Debt-106.79M USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity-0.10
Current Ratio7.65
Quick Ratio7.46
Book Value/Sh-5.1890 USD
Cash/Share4.038 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 5, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)34.57 USD
Target Range16.00 USD – 44.00 USD
# Analysts7
Ownership
Shares Out.29.38M
Float9.57M
Insiders53.68%
Institutions24.56%
Short Interest
Short Ratio12.3d
Short % Float17.04%
Short % Out.7.54%
Shares Short2.22M
Short (prev mo.)2.21M
Technical
SMA 506.804 (+1.6%)
SMA 2007.933 (-12.9%)
Beta0.56
S&P 52W Chg27.70%
Avg Vol (30d)162.82K
Avg Vol (10d)180.72K
Technical Indicators
RSI (14)54.4
MACD-0.0133
MACD Signal0.0393
MACD Hist.-0.0526
BB Upper9.153 USD
BB Middle7.391 USD
BB Lower5.629 USD
BB Width47.68%
ATR (14)0.6805 USD
Vol Ratio (20d)1.13x